Literature DB >> 1769963

Crystal structure of basic fibroblast growth factor at 1.6 A resolution.

H Ago1, Y Kitagawa, A Fujishima, Y Matsuura, Y Katsube.   

Abstract

We have determined the crystal structures of two types of human basic fibroblast growth factor, the serine analogue and the wild-type, at 1.6 and 2.5 A resolution, respectively. Two good heavy atom derivatives were found and used for multiple isomorphous replacement phasing. The atomic coordinates were refined using the Hendrickson & Konnert program for stereochemically restrained refinement against structure factors. The crystallographic R factors were reduced to 15.3% for the serine analogue structure and 16.0% for the wild-type structure. The serine analogue and wild-type structures have been found to be almost identical, the root-mean-square deviation between the corresponding C alpha atoms being 0.11 A. Their structures are composed of twelve beta-strands forming a barrel and three loops. Their molecules have an approximate threefold internal symmetry and are similar in architecture to that of interleukin-1 beta. A possible heparin-binding site, which comprises five basic residues, Lys119, Arg120, Lys125, Lys129, and Lys135, has been revealed by calculating the electrostatic potential energy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1769963     DOI: 10.1093/oxfordjournals.jbchem.a123586

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  23 in total

1.  Structure and stability effects of mutations designed to increase the primary sequence symmetry within the core region of a beta-trefoil.

Authors:  S R Brych; S I Blaber; T M Logan; M Blaber
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  Structural basis of trypsin inhibition and entomotoxicity of cospin, serine protease inhibitor involved in defense of Coprinopsis cinerea fruiting bodies.

Authors:  Jerica Sabotič; Silvia Bleuler-Martinez; Miha Renko; Petra Avanzo Caglič; Sandra Kallert; Borut Štrukelj; Dušan Turk; Markus Aebi; Janko Kos; Markus Künzler
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

3.  Bivalent carbohydrate binding is required for biological activity of Clitocybe nebularis lectin (CNL), the N,N'-diacetyllactosediamine (GalNAcβ1-4GlcNAc, LacdiNAc)-specific lectin from basidiomycete C. nebularis.

Authors:  Jure Pohleven; Miha Renko; Špela Magister; David F Smith; Markus Künzler; Borut Štrukelj; Dušan Turk; Janko Kos; Jerica Sabotič
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

4.  Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor.

Authors:  Regina Goetz; Mutsuko Ohnishi; Serkan Kir; Hiroshi Kurosu; Lei Wang; Johanne Pastor; Jinghong Ma; Weiming Gai; Makoto Kuro-o; Mohammed S Razzaque; Moosa Mohammadi
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

5.  Versatile loops in mycocypins inhibit three protease families.

Authors:  Miha Renko; Jerica Sabotic; Marko Mihelic; Joze Brzin; Janko Kos; Dusan Turk
Journal:  J Biol Chem       Date:  2009-10-21       Impact factor: 5.157

6.  Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development.

Authors:  P M Smallwood; I Munoz-Sanjuan; P Tong; J P Macke; S H Hendry; D J Gilbert; N G Copeland; N A Jenkins; J Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

7.  Interactions of putative heparin-binding domains of basic fibroblast growth factor and its receptor, FGFR-1, with heparin using synthetic peptides.

Authors:  L Kinsella; H L Chen; J A Smith; P S Rudland; D G Fernig
Journal:  Glycoconj J       Date:  1998-04       Impact factor: 2.916

8.  Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution.

Authors:  B S Chang; R M Beauvais; T Arakawa; L O Narhi; A Dong; D I Aparisio; J F Carpenter
Journal:  Biophys J       Date:  1996-12       Impact factor: 4.033

9.  Formulation design of acidic fibroblast growth factor.

Authors:  P K Tsai; D B Volkin; J M Dabora; K C Thompson; M W Bruner; J O Gress; B Matuszewska; M Keogan; J V Bondi; C R Middaugh
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

10.  Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution.

Authors:  A E Eriksson; L S Cousens; B W Matthews
Journal:  Protein Sci       Date:  1993-08       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.